StockData
Cencora, Inc. logo

Cencora, Inc. (COR) stock

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$350.56−6.38 (-1.79%)

Close on Nov 17, 2026Market cap $66.90BP/E 26.0Yield 0.63%

Cencora revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cencora's revenue for the twelve months ending Jun 30, 2026 was $332.77B, up 5.1% year over year. For fiscal 2025 it was $321.33B, up 9.3% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is $321.33B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Sep 30, 2025$321.33B+9.3%
FY2024Sep 30, 2024$293.96B+12.1%
FY2023Sep 30, 2023$262.17B+9.9%
FY2022Sep 30, 2022$238.59B+11.5%
FY2021Sep 30, 2021$213.99B+12.7%
FY2020Sep 30, 2020$189.89B+5.7%
FY2019Sep 30, 2019$179.59B+6.9%
FY2018Sep 30, 2018$167.94B+9.7%
FY2017Sep 30, 2017$153.14B+4.3%
FY2016Sep 30, 2016$146.85B+8.0%
FY2015Sep 30, 2015$135.96B+13.7%
FY2014Sep 30, 2014$119.57B+35.9%
FY2013Sep 30, 2013$87.96B+12.7%
FY2012Sep 30, 2012$78.08B-0.8%
FY2011Sep 30, 2011$78.70B+1.2%
FY2010Sep 30, 2010$77.78B+8.4%
FY2009Sep 30, 2009$71.76B+2.2%
FY2008Sep 30, 2008$70.19B+6.9%
FY2007Sep 30, 2007$65.67B–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$84.75B+5.1%
Q2 FY2026CQ1 2026Mar 31, 2026$78.36B+3.8%
Q1 FY2026CQ4 2025Dec 31, 2025$85.93B+5.5%
Q4 FY2025CQ3 2025Sep 30, 2025$83.73B+5.9%
Q3 FY2025CQ2 2025Jun 30, 2025$80.66B+8.7%
Q2 FY2025CQ1 2025Mar 31, 2025$75.45B+10.3%
Q1 FY2025CQ4 2024Dec 31, 2024$81.49B+12.8%
Q4 FY2024CQ3 2024Sep 30, 2024$79.05B+14.7%
Q3 FY2024CQ2 2024Jun 30, 2024$74.24B+10.9%
Q2 FY2024CQ1 2024Mar 31, 2024$68.41B+7.8%
Q1 FY2024CQ4 2023Dec 31, 2023$72.25B+15.0%
Q4 FY2023CQ3 2023Sep 30, 2023$68.92B+12.7%
Q3 FY2023CQ2 2023Jun 30, 2023$66.95B+11.5%
Q2 FY2023CQ1 2023Mar 31, 2023$63.46B+9.9%
Q1 FY2023CQ4 2022Dec 31, 2022$62.85B+5.4%
Q4 FY2022CQ3 2022Sep 30, 2022$61.17B+3.8%
Q3 FY2022CQ2 2022Jun 30, 2022$60.06B+12.5%
Q2 FY2022CQ1 2022Mar 31, 2022$57.72B+17.4%
Q1 FY2022CQ4 2021Dec 31, 2021$59.63B+13.5%
Q4 FY2021CQ3 2021Sep 30, 2021$58.91B+19.6%
Q3 FY2021CQ2 2021Jun 30, 2021$53.41B+17.7%
Q2 FY2021CQ1 2021Mar 31, 2021$49.15B+3.7%
Q1 FY2021CQ4 2020Dec 31, 2020$52.52B+9.7%
Q4 FY2020CQ3 2020Sep 30, 2020$49.24B+7.9%
Q3 FY2020CQ2 2020Jun 30, 2020$45.37B+0.3%
Q2 FY2020CQ1 2020Mar 31, 2020$47.42B+9.5%
Q1 FY2020CQ4 2019Dec 31, 2019$47.86B+5.4%
Q4 FY2019CQ3 2019Sep 30, 2019$45.64B+5.4%
Q3 FY2019CQ2 2019Jun 30, 2019$45.24B+4.9%
Q2 FY2019CQ1 2019Mar 31, 2019$43.32B+5.6%
Q1 FY2019CQ4 2018Dec 31, 2018$45.39B+12.2%
Q4 FY2018CQ3 2018Sep 30, 2018$43.30B+10.7%
Q3 FY2018CQ2 2018Jun 30, 2018$43.14B+11.5%
Q2 FY2018CQ1 2018Mar 31, 2018$41.03B+10.5%
Q1 FY2018CQ4 2017Dec 31, 2017$40.47B+6.0%
Q4 FY2017CQ3 2017Sep 30, 2017$39.12B+4.2%
Q3 FY2017CQ2 2017Jun 30, 2017$38.71B–
Q2 FY2017CQ1 2017Mar 31, 2017$37.15B–
Q1 FY2017CQ4 2016Dec 31, 2016$38.17B–
Q4 FY2016CQ3 2016Sep 30, 2016$37.56B–

More Cencora figures

See a number that looks wrong?